home-hero.jpg

Outsourcing for the pharmaceutical industry

Welcome to the Dishman Carbogen Amcis Ltd website. Our organization has embarked upon a new and exciting era; therefore, our online presence has undergone a complete refresh and total restructuring.

Please feel free to contact us with any queries or browse our newly refurbished corporate portal.

Our Mission

The mission of Dishman Carbogen Amcis Ltd and its fundamental purpose is to offer support and assistance to people across the world suffering from illness and disease, striving to ensure that this is completed efficiently, comprehensively, and effectively.

Latest News

  • Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)

    News

    Pascal Villemagne appointed new CARBOGEN AMCIS Chief Executive Officer (CEO)

    BUBENDORF, Switzerland (March 31, 2022) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces that Pascal Villemagne has been named Chief Executive Officer, effective first of April

    In his new role, Pascal Villemagne will be leading CARBOGEN AMCIS and its nine sites around the world. He will report to Arpit Vyas, Global Managing Director of Dishman Carbogen Amcis Ltd., CARBOGEN AMCIS’ parent company. Villemagne, who has served as Vice...

    Read more

  • Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    News

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on Clinical Research Study that reveals positive response in vitamin D deficiency/insufficiency in patients with COVID-19

    Ahmedabad, India (December 9th, 2021) — Dishman Carbogen Amcis Ltd, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new Clinical Research Study which shows that oral 25-Hydroxyvitamin D3 (Calcifediol) was able to correct vitamin D deficiency/insufficiency in patients with COVID-19 and that it resulted in improved immune function by increasing...

    Read more

  • Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency

    News

    Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency

    Ahmedabad, India (May 21th, 2021) — India-based Dishman Carbogen Amcis Ltd, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new study that provides critical insights into the treatment of vitamin D deficiency in obesity and in fat malabsorption syndromes. The research was conducted by Boston University School of Medicine and supported in part by a grant from Dishman Carbogen Amcis Ltd’s wholly-owned...

    Read more

  • CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    News

    CARBOGEN AMCIS announces major investments of more than CHF 100 million in Switzerland and France

    BUBENDORF, Switzerland (August 17, 2020) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today new expansion plans in Switzerland and France. 

    CARBOGEN AMCIS announces two major expansion projects that will increase manufacturing capacity to better meet the demands of the current market and its customers. The new facilities, located in Switzerland and France, will...

    Read more

  • Dishman Carbogen Amcis Ltd Statement on COVID-19

    News

    Dishman Carbogen Amcis Ltd Statement on COVID-19

    Dear Customers and Partners,

    We at Dishman Carbogen Amcis group of companies are taking the risks associated with COVID-19 very seriously, and have already implemented a set of measures aimed at limiting any risk to our employees, customers and patients. We have already established a dedicated working team who monitor the COVID-19 outbreak and all processes have been analyzed with regards to risks. This allows us to have all our operations running smoothly and we currently do not have an impact on our operations.

    We are facing a unique situation in several of the countries where...

    Read more

  • ISO22716 Cosmetics GMP standard accreditation

    News

    ISO22716 Cosmetics GMP standard accreditation

    BUBENDORF, Switzerland (May 22nd, 2019) — Switzerland-based CARBOGEN AMCIS AG, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announced today that its Manchester site successfully passed the accreditation for the ISO22716 Cosmetics GMP standard. 

    CARBOGEN AMCIS Ltd (Manchester) successfully passed two stages of audit in December 2018 and in March 2019 by a third-party certification body conducted by Lloyd's Register Quality Assurance Limited. The audit sessions were to assess the compliance of the Quality...

    Read more

    Upcoming events

    • Chemspec Europe 2023

      Chemspec Europe 2023

      Events

      ChemSpec Europe 2023

       

      The 36th International Exhibition for Fine and Speciality Chemicals will take place from 24 - 25 May 2023, at Messe Basel, Switzerland.

      With a highly specialised profile, Chemspec Europe is a key event for the fine and speciality chemicals industry. The exhibition is the place to be for purchasers and agents to meet with manufacturers, suppliers and distributors of fine and speciality chemicals to source specific solutions and bespoke products.

      Chemspec Europe is a powerful gateway to global business and industry knowledge, making the event appealing to its international audience. The exhibition features the full spectrum of fine and speciality chemicals for various applications and industries. 

      Additionally, a wide range of free conferences provides excellent opportunities to network with industry colleagues and exchange competencies on the latest market trends, technical innovations, business opportunities, and regulatory issues in an evolving market.

       

       

       

       

       

       

       

      OTHER EVENTS

      Company Profile

      CONTACT US TODAY OR DOWNLOAD
      OUR COMPANY PROFILE BROCHURE
      FOR FURTHER INFORMATION

      SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES

      Read more

    • CPhI China 2023

      CPhI China 2023

      Events

      CPhI China in Shanghai

       

      Each year CPhI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market.

      Our team from Shanghai will represent CARBOGEN AMCIS and Dishman Carbogen Amcis Ltd. at the CPhI China 2023. 
      Get in contact with us and let’s meet in Shanghai!

       

       

       

       

       

       

       

      OTHER EVENTS

      Company Profile

      CONTACT US TODAY OR DOWNLOAD
      OUR COMPANY PROFILE BROCHURE
      FOR FURTHER INFORMATION

      SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES

      Read more

    • CPhI Worldwide 2023

      CPhI Worldwide 2023

      Events

      CPhI Worldwide in Barcelona

       

      CPhI Worldwide will return to Barcelona from 24 - 26 October 2023!

      Over the last 30+ years, CPhI has provided a unique platform that unites specialist communities dedicated to improving healthcare. We offer a place where professionals can meet to exchange knowledge and do business without obstacles, helping to propel the pharmaceutical and healthcare industries forward.

      Visit us at booth 3G39.

       

       

       

       

       

       

      OTHER EVENTS

      Company Profile

      CONTACT US TODAY OR DOWNLOAD
      OUR COMPANY PROFILE BROCHURE
      FOR FURTHER INFORMATION

      SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES

      Read more

      QUARTERNARY AMMONIUM SALTS EXPLAINED

      Dishman Carbogen Amcis Ltd. has rich expertise in Quaternary Ammonium Salts (Quats) with a robust and established portfolio. But do you know about their many benefits and applications? Watch the video to learn more about the Quats and discover how they could benefit you.

      Key Figures

      COVID-19 UPDATE

      As part of our commitment to continue the long fight against COVID-19, we have doubled the manufacturing capacity of some of our disinfectant API production facilities. Since March 2020, we have manufactured and globally exported more than 300 metric tons of disinfectant APIs.

      A global presence with 10 sites in India, Switzerland, UK, France, Netherlands & China
      More than 30 years of experience in clinical API development
      From gram to several 100 metric tons scale manufacturing for API production
      More than 1150 m3 of capacity for API production
      Over 300 metric tons of disinfectant APIs manufactured and exported to fight COVID-19 since 03/2020

      CONTACT US TODAY OR DOWNLOAD
      OUR COMPANY PROFILE BROCHURE
      FOR FURTHER INFORMATION

      SUBSCRIBE TO OUR MAILING LIST FOR THE LATEST NEWS UPDATES